Literature DB >> 25078631

Stability of melphalan solution for intravitreal injection for retinoblastoma.

Emiliano Buitrago1, Eduardo Lagomarsino2, Gabriel Mato2, Paula Schaiquevich3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25078631     DOI： 10.1001/jamaophthalmol.2014.2324

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  5 in total

1.  INTRAVITREAL MELPHALAN AS SALVAGE THERAPY FOR REFRACTORY RETINAL AND SUBRETINAL RETINOBLASTOMA.

Authors:  Jasmine H Francis; Brian P Marr; Scott E Brodie; Pierre Gobin; Ira J Dunkel; David H Abramson
Journal:  Retin Cases Brief Rep       Date:  2016

2.  Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients.

Authors:  Carley M Bogan; Janene M Pierce; Stephanie D Doss; Yuankai K Tao; Sheau-Chiann Chen; Kelli L Boyd; Albert Liao; Terry Hsieh; David H Abramson; Jasmine H Francis; Debra L Friedman; Ann Richmond; Anthony B Daniels
Journal:  Exp Eye Res       Date:  2021-01-11       Impact factor: 3.467

3.  Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.

Authors:  Anthony B Daniels; Michael T Froehler; Janene M Pierce; Amy H Nunnally; M Wade Calcutt; Thomas M Bridges; David C LaNeve; Phillip E Williams; Kelli L Boyd; Michelle L Reyzer; Craig W Lindsley; Debra L Friedman; Ann Richmond
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

4.  Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma.

Authors:  Terry Hsieh; Albert Liao; Jasmine H Francis; Jessica A Lavery; Audrey Mauguen; Scott E Brodie; David H Abramson
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

Review 5.  Treatment of Retinoblastoma: What Is the Latest and What Is the Future.

Authors:  Paula Schaiquevich; Jasmine H Francis; María Belén Cancela; Angel Montero Carcaboso; Guillermo L Chantada; David H Abramson
Journal:  Front Oncol       Date:  2022-04-01       Impact factor: 5.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.